【Name of company】
Mitsubishi Tanabe Pharma Corporation
【Event】
Revision to Consolidated Financial Forecasts for Fiscal Year Ending March 31, 2019
【Presenter】
Managing Executive Officer Eizo Tabaru, Member of the Board
【Availability Period (JST)】
12:15 April 25,2019 〜
23:59 April 24,2020
23:59 April 24,2020